FDA gives thumbs up to Takeda's lung cancer drug
BioPharma Dive: Biotech and Pharma news | May 01, 2017
Japanese pharma Takeda Pharmaceuticals on Friday secured approval for its drug targeting a specific group of lung cancer patients, putting the company in direct competition with several other heavyweight drug developers.